Dec 20, 2019
GB Sciences Announces Outstanding Results from Preclinical Study of Its Parkinson's Disease Formulations
Dec 05, 2019
GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson's Disease and Neuropathic Pain
Oct 31, 2019
GB Sciences Welcomes Esteemed Patent and Intellectual Property Attorney, Mr. Edmond DeFrank, to Its Board of Directors
Jul 17, 2019
GB Sciences Files Novel Patent Application For Chronic Pain Treatments Based On Proprietary Cannabis-Derived Formulations
Jun 11, 2019
GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients
Mar 28, 2019
GB Sciences Study Shows Nevada's Cannabis Strain Names Have No Correlation to Active Ingredients
Mar 26, 2019
In Case You Missed It: GB Sciences Approved For Full Operations In Main LSU AgCenter Production Facility
Mar 22, 2019
Louisiana Agriculture Commissioner Approves GB Sciences To Begin Full Operations In Main LSU AgCenter Production Facility
Jan 16, 2019
GB Sciences Completes Harvest of First Cannabis Crop in Partnership with The Louisiana State University Agricultural Research Center
Dec 12, 2018
Exploring the Lesser Cannabinoids - The Happy Accident of CBN
Dec 11, 2018
Dr. Andrea Small-Howard, GB Sciences' Chief Science Officer, Introduces, "Unique Methods to Identify Strong Lead Compounds" at the International Cannabinoid Derived Pharmaceutical Summit
Nov 20, 2018
GB Sciences Files First Of Its Kind Provisional Patent Application For The Treatment Of Neuropathic Pain Using Time-Released, Myrcene-Based Nanoparticles
Nov 14, 2018
More From Meredith Patterson, GB Sciences' Brain Nurse, As She Examines the Workings of CBD
Nov 14, 2018
GB Sciences Expands into the Oklahoma Medical Cannabis Market
Nov 01, 2018
GB Sciences Sponsors "2018 Innovation In Medical Cannabis Therapies" Symposium
Oct 02, 2018
GB Sciences' Drug Development Program Benefits from Establishment of Clear Pathway for Cannabis-Based Drug Approvals and Commercialization
Aug 23, 2018
The State of Louisiana Pharmacy Board Has Selected Nine Initial Pharmacies to Dispense Medical Cannabis Formulations Through the GB Sciences and LSU Agriculture Center Partnership
Aug 06, 2018
Michigan State University's Dr. Norbert Kaminski Begins Pre-Clinical Study of GB Sciences' Neuroprotective Cannabis Compounds For Parkinson's Disease
Jul 09, 2018
GB Sciences One of Ten Companies Named in Important New Canadian Research Publication
Jun 25, 2018
GB Sciences Files Patents for Heart Disease and Chronic, Immunological, and Neuropathic Pain